StockComparison Logo
vs

ABOS vs XGN

Comparison between Acumen Pharmaceuticals Inc (ABOS, Company) and Exagen Inc (XGN, Company).

Both ABOS and XGN are from the Healthcare sector.

5-Year PerformanceXGN has outperformed ABOS, delivering a return of -8.7% compared to -31.6%

ABOS vs XGN - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
ABOS
$162M
XGN
$161M
Max Drawdown
ABOS
95.56%
Winner
XGN
95.22%
Sharpe Ratio
Winner
ABOS
0.98
XGN
-0.03
5Y Beta
Winner
ABOS
1.43
XGN
1.70
Industry
ABOS
Biotechnology
XGN
Diagnostics & Research
P/E Ratio
ABOS
-1.23
Winner
XGN
-8.15
5Y EPS CAGR
ABOS
N/A
XGN
-9.18%
Debt to Equity
Winner
ABOS
35.49%
XGN
186.96%
Free Cash Flow Yield
ABOS
-65.24%
Winner
XGN
-4.72%

ABOS vs XGN - Historical Returns

Returns include dividend reinvestment.

1M
ABOS
-16.10%
Winner
XGN
+51.14%
3M
ABOS
-11.11%
Winner
XGN
+115.21%
6M
ABOS
-0.44%
Winner
XGN
+97.92%
1Y
Winner
ABOS
+64.71%
XGN
-25.03%
5Y(CAGR)
ABOS
-31.63%
Winner
XGN
-8.73%
Max(CAGR)
ABOS
-34.99%
Winner
XGN
-13.88%

ABOS vs XGN - Annual Returns (2019 - 2026)

Returns include dividend reinvestment.

YearABOSXGN
2026+10.89%+10.10%
2025+14.05%+96.76%
2024-59.34%+108.12%
2023-27.00%-19.11%
2022-19.76%-78.30%
2021-66.37%-16.33%
2020N/A-49.13%
2019N/A+36.71%

ABOS vs XGN Drawdown Comparison

The maximum drawdown for ABOS was -95.56%, occurring on Apr 17, 2025. This drawdown has not yet recovered.

The maximum drawdown for XGN was -95.22%, occurring on May 1, 2024. This drawdown has not yet recovered.

The current ABOS drawdown is -88.95%. The current XGN drawdown is -76.65%.

RankABOSXGN
#1-95.56%
Jul 2, 2021 - Apr 17, 2025
-95.22%
Dec 26, 2019 - May 1, 2024
#2N/A-32.13%
Sep 19, 2019 - Nov 5, 2019
#3N/A-16.54%
Nov 6, 2019 - Dec 18, 2019

Correlation

Correlation between ABOS and XGN is 0.47 which considered as a weak positive correlation - the stocks show a slight tendency to move together.

0.47
-101

Select Stocks to Compare